http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0375662-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cac023d2e2874224ecbbcccbdea1fc91
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
filingDate 1985-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05c8f3e8e351f39a4bb05cbed4874628
publicationDate 1990-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0375662-A2
titleOfInvention Controlled-release rectal pharmaceutical preparation
abstract A controlled-release pharmaceutical preparation of 3-­isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine. The controll­ed-release preparation is in the form of rectal suppository containing 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine. Further the controlled-release is prepared by implanting 3-­isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine in an oleagi­nous base.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293277-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8323641-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8236352-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309136-B2
priorityDate 1984-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19977152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70350485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235658101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21641045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129447585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235658100

Total number of triples: 41.